Endocrine, Metabolic & Immune Disorders - Drug Targets

(Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders)

Editor-in-Chief:

Emilio Jirillo
Department of Basic Medical Sciences Neuroscience and Sensory Organs
University of Bari “Aldo Moro”
Bari
Italy

Back

Become EABM
Become Reviewer

Celiac Disease: Pathogenesis and Novel Therapeutic Strategies

Volume:8   Issue: 3
Pp: 152-158
Mariella Baldassarre, Anna Maria Laneve, Roberto Grosso and Nicola Laforgia
DOI: 10.2174/187153008785700109

Cannabinoids as Therapeutic Agents for Ablating Neuroinflammatory Disease

Volume:8   Issue: 3
Pp: 159-172
G. A. Cabral and L. Griffin-Thomas
DOI: 10.2174/187153008785700118

Genome Study of Kidney Disease in the Age of Post Genome-Sequencing

Volume:8   Issue: 3
Pp: 173-183
Kent Doi, Koji Okamoto, Katsushi Tokunaga, Toshiro Fujita and Eisei Noiri
DOI: 10.2174/187153008785700136

Harnessing CD36 to Rein in Inflammation

Volume:8   Issue: 3
Pp: 184-191
M. S. Parsons, L. Barrett, C. Little and M. D. Grant
DOI: 10.2174/187153008785700073

Trends in Metabolic Syndrome and Gene Networks in Human and Rodent Models

Volume:8   Issue: 3
Pp: 198-207
Aldi T. Kraja, Michael A. Province, Pinchia Huang, Joseph P. Jarvis, Treva Rice, James M. Cheverud and D. C. Rao
DOI: 10.2174/187153008785700145